Literature DB >> 8218846

Treatment of autoimmune diseases by oral tolerance to autoantigens.

H L Weiner1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8218846     DOI： 10.3109/08916939309008850

Source DB:  PubMed          Journal:  Autoimmunity        ISSN： 0891-6934            Impact factor:   2.815


× No keyword cloud information.
  5 in total

Review 1.  Oral tolerance.

Authors:  W Strober; B Kelsall; T Marth
Journal:  J Clin Immunol       Date:  1998-01       Impact factor: 8.317

2.  Naturally processed heterodimeric disulfide-linked insulin peptides bind to major histocompatibility class II molecules on thymic epithelial cells.

Authors:  F Forquet; M Hadzija; J W Semple; E Speck; T L Delovitch
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

3.  Interleukin-2 treatment potentiates induction of oral tolerance in a murine model of autoimmunity.

Authors:  L V Rizzo; N E Miller-Rivero; C C Chan; B Wiggert; R B Nussenblatt; R R Caspi
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

4.  Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin.

Authors:  J C Carel; P Bougnères; P Vardi
Journal:  J Endocrinol Invest       Date:  1994 Jul-Aug       Impact factor: 4.256

5.  Monocyte chemotactic protein 1 regulates oral tolerance induction by inhibition of T helper cell 1-related cytokines.

Authors:  W J Karpus; K J Kennedy; S L Kunkel; N W Lukacs
Journal:  J Exp Med       Date:  1998-03-02       Impact factor: 14.307
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.